Table 5 Comparison Genotype and allele frequencies of rs5882 with risk of CAD in healthy and patient men and women
Polymorphism | Genotypes | Â | Alleles | |||||
|---|---|---|---|---|---|---|---|---|
GG (%) | GA (%) | AA (%) | p-value | G | A | O.R (95% CI) | p-value | |
Men | Â | Â | Â | Â | Â | Â | Â | Â |
CETP rs5882 | Â | Â | Â | Â | Â | Â | 2.54 (1.44, 4.48) | Â |
Controls (n = 42) | 8 (19%) | 21 (50%) | 13 (30.9%) | 0.007 | 37 (44.0%) | 47 (56.0%) | 0.001 | |
Patients (n = 63) | 30 (47.7%) | 24 (38%) | 9 (14.3%) | 84 (66.6%) | 42 (33.3%) |  | ||
Women | Â | Â | Â | Â | Â | Â | Â | Â |
CETP rs5882 | Â | Â | Â | Â | Â | Â | 0.79 (0.44, 1.42) | Â |
Controls (n = 58) | 20 (34.5%) | 31 (53.5%) | 7 (12%) | 0.695 | 71 (61.2%) | 45 (38.8%) | 0.428 | |
Patients (n = 37) | 10 (27%) | 21 (56.8%) | 6 (16.2%) | 41 (55.4%) | 33 (44.6%) |  | ||